Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• The cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway is crucial for innate immune response and cancer immunotherapy.
• Current STING agonists face limitations due to poor tumor responsiveness and activation efficiency.
• Achieving effective and responsive cGAS-STING activation within tumors remains a significant challenge.

Purpose of the Study:

• To develop a novel manganese-based nanoplatform (MPCZ NPs) for responsive and efficient activation of the cGAS-STING signaling pathway.
• To enhance cancer immunotherapy by overcoming the limitations of existing STING agonists.

Main Methods:

• Constructed MPCZ NPs by loading manganese dioxide (MnO2) with zinc protoporphyrin IX (ZPP) and coating with polydopamine (PDA) embedded with NH4HCO3.
• Investigated the in vitro and in vivo antitumor effects of MPCZ NPs using MTT and TUNEL assays.
• Evaluated the responsive generation of manganese ions (Mn2+) and reactive oxygen species (ROS) under exogenous (laser irradiation) and endogenous (GSH) stimuli.

Main Results:

• MPCZ NPs demonstrated tumor responsiveness through the degradation of PDA and MnO2 triggered by laser irradiation and high GSH levels.
• Released Mn2+ augmented the cGAS-STING pathway and enhanced ROS production (H2O2 to ·OH) under near-infrared (NIR) laser irradiation.
• ZPP release and GSH elimination by MPCZ NPs inhibited HO-1 activity and prevented ROS consumption, respectively, further boosting the therapeutic effect.

Conclusions:

• The developed nanoplatform effectively generates ROS and Mn2+ to responsively activate the cGAS-STING pathway.
• This strategy offers a promising new approach for improving cancer immunotherapy outcomes.
• The study highlights an open-source, cost-effective method for enhancing immune responses against tumors.